Kalp, M., Bethel, C. R., Bonomo, R. A., & Carey, P. R. (2009). Why the Extended-Spectrum β-Lactamases (ESBLs) SHV-2 and SHV-5 are “Hyper-Susceptible” to Mechanism-Based Inhibitors.
Citação norma ChicagoKalp, Matthew, Christopher R. Bethel, Robert A. Bonomo, e Paul R. Carey. Why the Extended-Spectrum β-Lactamases (ESBLs) SHV-2 and SHV-5 Are “Hyper-Susceptible” to Mechanism-Based Inhibitors. 2009.
Citação norma MLAKalp, Matthew, Christopher R. Bethel, Robert A. Bonomo, e Paul R. Carey. Why the Extended-Spectrum β-Lactamases (ESBLs) SHV-2 and SHV-5 Are “Hyper-Susceptible” to Mechanism-Based Inhibitors. 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.